Krystal Biotech, Inc. — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2020-02-18

Reporting Person: Krishnan Krish S (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	S	7481	$62.2594	Disposed	1978981	Direct
2020-02-18	Common Stock	S	4588	$62.9754	Disposed	1974393	Direct
2020-02-18	Common Stock	S	600	$63.9533	Disposed	1973793	Direct
2020-02-19	Common Stock	S	16033	$62.6962	Disposed	1957760	Direct
2020-02-19	Common Stock	S	2617	$63.1466	Disposed	1955143	Direct
2020-02-20	Common Stock	S	2192	$59.596	Disposed	1952951	Direct
2020-02-20	Common Stock	S	10022	$60.7054	Disposed	1942929	Direct
2020-02-20	Common Stock	S	3561	$61.5209	Disposed	1939368	Direct
2020-02-20	Common Stock	S	2906	$62.3769	Disposed	1936462	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	112162	Indirect
Common Stock	2001462	Indirect

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F2: This transaction was executed in multiple trades ranging from $61.64 to $62.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: This transaction was executed in multiple trades ranging from $62.64 to $63.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: This transaction was executed in multiple trades ranging from $63.91 to $64.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F5: This transaction was executed in multiple trades ranging from $62.00 to $63.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F6: This transaction was executed in multiple trades ranging from $63.00 to $64.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F7: This transaction was executed in multiple trades ranging from $59.06 to $60.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F8: This transaction was executed in multiple trades ranging from $60.06 to $61.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F9: This transaction was executed in multiple trades ranging from $61.06 to $62.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F10: This transaction was executed in multiple trades ranging from $62.07 to $63.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

F11: Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.

F12: Directly beneficially owned by Suma S. Krishnan, the spouse of the reporting person.